Green Square Capital Advisors LLC Gilead Sciences, Inc. Transaction History
Green Square Capital Advisors LLC
- $710 Million
- Q3 2024
A detailed history of Green Square Capital Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Green Square Capital Advisors LLC holds 24,932 shares of GILD stock, worth $2.24 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
24,932
Previous 25,390
1.8%
Holding current value
$2.24 Million
Previous $1.74 Million
19.92%
% of portfolio
0.29%
Previous 0.24%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
1,931Shares Held
991MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.88 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.55 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.41 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...